Evidence map›Paper›PMID 30130365›Full record

ArticlePloS one2018

Sequencing of Treponema pallidum subsp. pallidum from isolate UZ1974 using Anti-Treponemal Antibodies Enrichment: First complete whole genome sequence obtained directly from human clinical material.

Linda Grillová, Lorenzo Giacani, Lenka Mikalová, Michal Strouhal, Radim Strnadel, Christina Marra, Arturo Centurion-Lara, Lucy Poveda, Giancarlo Russo, Darina Čejková and 3 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Linda GrillováDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Lorenzo GiacaniDepartment of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, United States of America.
Lenka MikalováDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Michal StrouhalDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Radim StrnadelDepartment of Dermatovenerology, University Hospital Brno, Brno, Czech Republic.
Christina MarraDepartment of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, United States of America.
Arturo Centurion-LaraDepartment of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, United States of America.
Lucy PovedaFunctional Genomics Center Zurich, University of Zurich, Zurich, Switzerland.
Giancarlo RussoFunctional Genomics Center Zurich, University of Zurich, Zurich, Switzerland.
Darina ČejkováDepartment of Immunology, Veterinary Research Institute, Brno, Czech Republic.
Vladimír Vašků1st Dermatovenereological Clinic St. Anne´s University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Jan OppeltCEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.ORCID 0000-0002-3076-4840
David ŠmajsDepartment of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.ORCID 0000-0002-4176-3464
Masaryk University · CZUniversity of Washington · USUniversity of Zurich · CHCentral European Institute of Technology · CZUniversity Hospital Brno · CZVeterinary Research Institute · CZ

Funding

Pathoadaptive Mutations in Treponema Pallidum, the SyphilisR21AI094126 · NIAID · UNIVERSITY OF WASHINGTON · PI GIACANI, LORENZO · 2012 to 2013
$425k
NIAID NIH HHS R21 AI094126
6 · The paper itself

Abstract

Treponema pallidum subsp. pallidum (TPA) is the infectious agent of syphilis, a disease that infects more than 5 million people annually. Since TPA is an uncultivable bacterium, most of the information on TPA genetics comes from genome sequencing and molecular typing studies. This study presents the first complete TPA genome (without sequencing gaps) of clinical isolate (UZ1974), which was obtained directly from clinical material, without multiplication in rabbits. Whole genome sequencing was performed using a newly developed Anti-Treponemal Antibody Enrichment technique combined with previously reported Pooled Segment Genome Sequencing. We identified the UW074B genome, isolated from a sample previously propagated in rabbits, to be the closest relative of the UZ1974 genome and calculated the TPA mutation rate as 2.8 x 10(-10) per site per generation.

Indexed as

Whole Genome SequencingAnimalsGenetic VariationGenome, BacterialHumansMutation RatePhylogenyRabbitsSequence Analysis, DNASyphilisTreponema pallidum

Identifiers

PMID30130365
PMCPMC6103504
OpenAlexW2888288078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.